Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE
· Real-Time Price · USD
6.24
0.19 (3.14%)
At close: May 29, 2025, 3:59 PM
6.45
3.45%
After-hours: May 29, 2025, 07:18 PM EDT
3.14% (1D)
| Bid | 5.8 |
| Market Cap | 961.03M |
| Revenue (ttm) | 104.94M |
| Net Income (ttm) | -112.33M |
| EPS (ttm) | -0.75 |
| PE Ratio (ttm) | -8.31 |
| Forward PE | -5.87 |
| Analyst | Buy |
| Ask | 6.45 |
| Volume | 758,846 |
| Avg. Volume (20D) | 1,522,352 |
| Open | 6.14 |
| Previous Close | 6.05 |
| Day's Range | 6.05 - 6.28 |
| 52-Week Range | 4.25 - 16.74 |
| Beta | -0.92 |
Analyst Forecast
According to 0 analyst ratings, the average rating for WVE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-17.08%
Shares of vaccine and gene therapy stocks are trad...
Unlock content with
Pro Subscription
1 month ago
+7.47%
Wave Life Sciences shares are trading higher after Cantor Fitzgerald initiated coverage with an Overweight rating and $10 price target.
2 months ago · seekingalpha.com
Wave Life Sciences: Potential For Accelerated Approval Pathway With WVE-N531Wave Life Sciences Ltd. release of multi-dose data from the phase 1b/2a open-label RestorAAtion-2 study, using WVE-006 for AATD-related lung disease, expected in 2025. Positive results were achieved i...
